Shopping Cart 0
Cart Subtotal
USD 0

Europe POCT Devices Market Outlook to 2022 - by Geography (Western Europe & Eastern Europe), by Product (Blood Glucose POCT, Infectious POCT, Cardiac POCT, Rapid Coagulation POCT, Blood Gas & Electrolytes POCT, Hematology POCT, Pregnancy POCT, Urinalysis POCT, Cholesterol POCT, Fecal Occult POCT, Hb1Ac POCT & Drugs of Abuse POCT), by Customer Segments (Hospitals & Clinics, Diagnostics Labs & Primary Care Units and Homecare & Patients)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4500

USD 3375

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 5200

USD 3900

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 9000

USD 6750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

The report titled "Europe POCT Devices Market Outlook to 2022 - by Geography (Western Europe & Eastern Europe), by Product (Blood Glucose POCT, Infectious POCT, Cardiac POCT, Rapid Coagulation POCT, Blood Gas & Electrolytes POCT, Hematology POCT, Pregnancy POCT, Urinalysis POCT, Cholesterol POCT, Fecal Occult POCT, Hb1Ac POCT & Drugs of Abuse POCT), by Customer Segments (Hospitals & Clinics, Diagnostics Labs & Primary Care Units and Homecare & Patients)" provides a comprehensive analysis of Europe POCT devices market evolution and overview, market ecosystem, market nature, value chain & entity analysis (OEM’s, C&F agents, distributors, retailers & customers), market size, and market segments by Geography (Western Europe & Eastern Europe), by Product (Blood Glucose POCT, Infectious POCT, Cardiac POCT, Rapid Coagulation POCT, Blood Gas & Electrolytes POCT, Hematology POCT, Pregnancy POCT, Urinalysis POCT, Cholesterol POCT, Fecal Occult POCT, Hb1Ac POCT & Drugs of Abuse POCT), by Customer Segments (Hospitals & Clinics, Diagnostics Labs & Primary Care Units and Homecare & Patients) and by Instruments and Consumables. Competition landscape, competition nature, major competition parameters and market share of major companies along with company profiles of Alere, Roche Holding AG, Siemens Healthineers, Becton Dickinson, Sysmex Corporation, EKF Diagnostics Holding, PTS Diagnostics, Werfen, Danaher Corporation, A. Menarini Diagnostics, Trinity Biotech, FujiFilm and others have been profoundly covered in the report. The report underscores prevailing government rules and regulation along with analyst recommendation to highlight the major opportunities and cautions.

The report is useful for POCT Devices manufacturers, distributors, retailers, potential entrants and other stakeholders to align their market centric strategies according to ongoing and expected trends in the future.

Europe POCT Devices Market Size and Overview

Market Size: Europe POCT Devices Market has grown registering a robust CAGR of close to 8% during the review period. Currently, the market is in growth stage with high potential of future expansion in both developed and developing countries of the region. Various factors supporting growth include high incidence of chronic diseases, rising health awareness, medical advancement in POCT sector, advancement in medical knowledge and R&D work, unease associated with laboratory testing methods and new companies venturing the market. Increase in urban population especially in the metro-cities which has been the largest end-user segment of the market and higher spending on R&D activities by the companies has led to the rise in number of point of care testing devices & customer interest. A substantial increase in awareness amongst population in cities & smaller towns has provided major thrust to this market. In parallel, growth & popularity of pregnancy & blood glucose POCT and advancement in technologies have given rise to new and improved devices. Advent of deadly infectious and cardiac diseases has led people to use these devices for quick detection. However, the market has been flooded with “fake” products, found all throughout the value chain.

Market Segmentation

By Geography: Western Europe has led the overall European scenario in terms of sales of POCT devices in 2017. Advanced medical infrastructure, higher level of disposable income of people, higher awareness and spending on healthcare, presence of well established manufacturers and government support has enabled countries such as the UK, France and Germany to lead the overall European landscape in terms of both, sales and demand in the review period.

By Product: Blood Glucose POCT devices led the market with highest sales revenue in 2017. The devices are used on routine basis to monitor glucose levels for people at home or for patients under tight glycemic control requirements. This segment was followed by Infectious, Cardiac, Rapid Coagulation, Blood Gas and Electrolytes, Hematology, Pregnancy POCT, Urinalysis POCT, Cholesterol Fecal Occult, Drugs of Abuse and Hb1Ac POCT devices respectively.

By Customer Segment: Hospitals and Clinics have been the largest customers of POCT devices in Europe in 2017. The entity uses these devices for diagnostics, treatment, monitoring and rapid testing. The tests carried out consists of TB, HIV, Malaria, Syphilis, Dengue, Strep A, HBV, C Diff, CD, 4, HCV, MRSA, Flu, UTI, Viral and others. Diagnostic labs and primary care units constitute for second largest share in the market. Home care and patients occupied lowest share owing to low volume sales and low replacement demand. Major motive to buy a POCT device for home patients is self assessment & referral and cost reduction.

By Instruments and Consumables: Instruments comprise of an apparatus or a machine that is used in the diagnosis of an illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for some health purpose. Consumables primarily comprise of strip based instruments such as Electrochemical or reflectance strip-based glucose meters and INR analyzers. HbA1c, Pregnancy, Cholesterol and Drug of Abuse POCT devices utilize consumables in large scale for diagnostics.

Competitive Landscape
Competition in the market has been concentrated among 6 major & 10-15 smaller companies in 2017. These include Radiometer, Werfen, Siemens, Roche, Nova, Alere and others. Major competition is being driven through new product launches, innovation and marketing initiatives. Products are being manufactured domestically as well as imported.

Future Outlook and Tailwind
Market has been anticipated to showcase a substantial growth at a CAGR of close to 6% during the forecast period. Increase in the number of new entrants in the market, larger product acceptance, new product launches, expanding distribution channels of existing players and higher marketing expenditure done by the companies are expected to be tailwind for future growth.

Key Topics Covered in the Report

  • Europe POCT Devices Market Introduction & Timeline
  • Europe POCT Devices Market Size, 2012-2017
  • Market Segmentation by Geography (Western Europe & Eastern Europe), by Product (Blood Glucose POCT, Infectious POCT, Cardiac POCT, Rapid Coagulation POCT, Blood Gas & Electrolytes POCT, Hematology POCT, Pregnancy POCT, Urinalysis POCT, Cholesterol POCT, Fecal Occult POCT, Hb1Ac POCT & Drugs of Abuse POCT), by Customer Segments (Hospitals & Clinics, Diagnostics Labs & Primary Care Units and Homecare & Patients) and by Instruments and Consumables.
  • Company Profiles of Major Manufacturers (Alere, Roche Holding AG, Siemens Healthineers, Becton Dickinson, Sysmex Corporation, EKF Diagnostics Holding, PTS Diagnostics, Werfen, Danaher Corporation, A. Menarini Diagnostics, Trinity Biotech, FujiFilm and others)
  • Value Chain Analysis Europe POCT Devices Market
  • Government Rules and Regulations for Europe POCT Devices Market
  • Growth Drivers in Europe POCT Devices Market
  • Major Market restraints in Europe POCT Devices Market
  • Future Outlook to Europe POCT Devices Market
  • Analyst Recommendation
READ MORE

Table Of Content

Scope

1. Research Methodology-Market Definitions

1.1 Abbreviations
1.2. Consolidated Research Approach
1.3. Research Methodology-Market Sizing and Limitations
1.4. Research Methodology - Variables (Dependent and Independent)

Variables Considered:

1.5. Research Methodology – Europe POCT Devices Market
1.6. Research Methodology – Europe POCT Devices Market

2. Europe POCT Devices-Executive Summary

3. Europe POCT Market Ecosystem: Vendor Landscape

4. Europe POCT Devices Market: Timeline & Genesis

5. Europe POCT Devices Market Value Chain Analysis -Overview

5.1. Value Chain Analysis for Europe POCT Devices Market-Networking
5.2. Entity Analysis: POCT Device Manufacturers (OEMs)
5.3. Entity Analysis: GPO, IDN, Stockists & Regional Distributors
5.4. Entity Analysis: Retailers (Pharmacy Chains & E-Commerce)
5.5. Entity Analysis: Final Consumers (Retail & Institutional)

6. Europe Point of Care Testing Devices Market, 2012-2017

7. Europe Point of Care Testing Market Key Trends & Growth Drivers

8. Europe Point of Care Testing Devices Market Segmentation by Product Type on the Basis of Revenue, 2017

8.1. Europe POCT Devices Market Segmentation by Product Type-Eastern and Western Europe
8.2. Europe POCT Devices Market New Technology Advancements
8.3. Blood Glucose Point of Care Testing, 2017
8.4. HbA1c Point-of Care Testing, 2017
8.5. Point-Cholesterol Point of Care Testing Devices, 2017
8.6. Blood Gas and Electrolytes Point of Care Testing Devices, 2017
8.7. Infectious Point of Care Testing Devices, 2017
8.8. Pregnancy Point of Care Testing Devices, 2017
8.9. Rapid Coagulation Point of Care Testing Devices, 2017
8.10 Drug of Abuse Point of Care Testing Devices, 2017
8.11. Cardiac POCT Devices, 2017
8.12. Hematology POCT Devices, 2017
8.13. Urinalysis & Faecal Occult POCT Devices, 2017

9. Europe POCT Devices Market Segmentation by Countries, 2017

9.1 Germany
9.2 Italy
9.3. Spain
9.4. UK
9.5. Scandinavian Countries
9.6. France
9.7. Russia
9.8. Poland
9.9 Greece

10. POCT Devices Market Segmentation by B2B & B2C Customer Type, 2017

11. POCT Market Segmentation by Instruments & Consumables, 2017

12. Government Regulations: Product Definitions and Essential Requirements

12.1. Government Regulations Involving Information Supplied by Manufacturer
12.2. Government Regulations: Product Definitions and Essential Requirements
12.3. Government Regulations: Product Definitions and Essential Requirements (Germany and United Kingdom)

13. Company Profile

13.1. Alere Inc.
13.2. Roche Holding AG
13.3. Siemens Healthineers
13.4. Becton Dickinson
13.5. Sysmex Corporation
13.6. Entwicklung, Konstruktion und Fertigung (EKF) Diagnostics Holding
13.7. PTS Diagnostics
13.8. Werfen
13.9. Danaher Corporation
13.10. A. Menarini Diagnostics
13.11. Other Companies

14. Europe Point of Care Test Devices Future Market Outlook and Projections, 2018E-2022E

14.1. Market Segmentation by Product Category, 2022E

15. Analyst Recommendations


List Of Figure

Figure 1.1 Tentative Respondents breakdown by Entities 
Figure 2.1: Europe POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 2.2 Europe POCT Devices Market Segmentation by Product on the basis of Revenue in %, 2017
Figure 2.3: Europe POCT Devices Key Market Matrix
Figure 3.1. Europe POCT Devices Market Ecosystem Including Vendor Landscape and Device Retailors
Figure 4.1. Europe POCT Market Timeline Including Establishment or Commencement of POCT Related Operations in Europe and Market Push Factors.
Figure 5.1: Europe POCT Market Product Development and Supply Chain Consisting of Major Entities and Sales Shares.
Figure 5.2: Modes of Product Pitching, Dealer Networks, Marketing Channels, Incentive Programs, Margins Charged by Major Entities in Europe POCT Devices Market.
Figure 6.1: Europe POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2017
Figure 6.2: Western Europe POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2017
Figure 6.3: Eastern Europe POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2017
Figure 8.1: Europe POCT Devices Market Segmentation by Product Type on the Basis of Revenue Generated in Percentage, 2017
Figure 8.2: Europe POCT Devices Market Segmentation by Product Type in Percentage for Eastern and Western Europe, 2017
Figure 8.3: Blood Glucose POCT Devices Market Segment Including Product Genesis, Strengths & Weakness, 2017
Figure 8.4: Blood Glucose POCT Devices Market Segment country wise analysis including major players, recent development and others, 2017
Figure 8.5: Infectious POCT Devices Market Including European Union Horizon 2020 Program, RSV Infection Project, Different Types of Infectious Diseases and others, 2017
Figure 9.1: Market Share of Major Countries in Europe POCT Devices Market by Revenue Generation, 2017
Figure 9.2: Market Share of Major Countries in Eastern Europe POCT Devices Market by Revenue Generation, 2017
Figure 9.4: Germany Market Segmentation by Product Categories on the Basis of Revenue Generated in %, 2012 and 2017
Figure 9.5: Germany Market Segmentation by Customer Segment on the Basis of Revenue Generated in %, 2017
Figure 9.7: Italy POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 9.8: Italy POCT Market Segmentation by Product Categories on the Basis of Revenue Generated in %, 2017
Figure 9.9: Italy POCT Market Segmentation by Instruments & Consumables on the Basis of Revenue Generated in %, 2017
Figure 9.10: Italy POCT Market Segmentation by Clientele on the Basis of Revenue Generated in %, 2017
Figure 9.11: Market Share of Major Players in Italy POCT Market on the Basis of Revenue Generated in %, 2017
Figure 9.12: Spain POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 9.13: UK POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 9.14: Scandinavian Countries POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 9.15: Market Share of Various (Sweden, Norway and Denmark) Scandinavian Countries POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 9.16: France POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 9.17: France Market Segmentation by Product Categories on the Basis of Revenue Generated in %, 2017
Figure 9.18: France Market Segmentation by Instruments & Consumables on the Basis of Revenue Generated in %, 2017
Figure 9.19: France Market Segmentation by End Users on the Basis of Revenue Generated in %, 2017
Figure 9.20: Greece POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 9.21: Greece Market Segmentation by End Users on the Basis of Revenue Generated in %, 2017
Figure 9.22: Greece Market Segmentation by Instruments & Consumables on the Basis of Revenue Generated in %, 2017
Figure 9.23: Italy Market Share of Major Players in Blood Gas and Electrolytes on the Basis of Revenue Generated in %, 2017
Figure 9.24: Italy Market Share of Major Players on the Basis of Revenue Generated in %, 2017
Figure 10.1: *Europe POCT Devices Market Segmentation by Customer Type (B2B & B2C) by Revenue, 2017
Figure 11.1: Europe POCT Market Segmentation by Instruments and Consumables on the basis of Revenue Generated, 2017
Figure 13.1: Competition Parameters amongst Leading Players in the Market, 2017
Figure 13.2: Market Share of Major Players in Europe on the Basis of Revenue Generated in %, 2017
Figure 13.3: Market Share of Major Players in Western Europe POCT Devices Market by Revenue Generation, 2017
Figure 13.4: Alere Revenue Growth in USD Billion, 2012-2016
Figure 13.5: Alere Loss Before Tax in USD Million, 2012-2016
Figure 13.6: Alere Revenue by Region in Percentage, 2016
Figure 13.7: Alere Segment Revenue in Percentage, 2016
Figure 13.8 : Alere Professional Diagnostics Segmentation by Sub Categories on the basis of Revenue in %, 2012-2016
Figure 13.9: Roche Holding AG European Presence Including Sales Sites, Manufacturing Sites, R&D Sites and Headquarters, 2017
Figure 13.10: Roche Diagnostics Revenue Growth in Euro Billion, 2012-2017
Figure 13.11: Roche Holding AG Products offered, Diseases Diagnosed, Solutions and Personalized Treatment Theory.
Figure 13.12: Siemens Healthineers Revenue Growth in Euro Billion, 2013-2017
Figure 13.13: Siemens Healthineers Profit Earned in Euro Billion, 2013-2017
Figure 13.14: Simens Healthineers Number of Orders Billion, 2013-2017
Figure 13.15: Simens Healthineers Profit Margin in Percentage, 2013-2017
Figure 13.16: Siemens Healthineers Revenue Segmentation by Location of Customers in %, 2013-2017
Figure 13.17: Siemens Healthineers Revenue Segmentation by Location of Companies in %, 2013-2017
Figure 13.18: Becton Dickinson Revenue Growth in USD Million, 2013-2017
Figure 13.19: Becton Dickinson Segment Revenue in %, 2013-2017
Figure 13.20 Sysmex Corporation Revenue Growth in USD Billion, 2013-2017
Figure 13.21: Sysmex Corporation Operating Profit in USD Million, 2013-2017
Figure 13.22: Sysmex Corporation Product Segment Revenue in %, 2016-2017
Figure 13.23: Sysmex Corporation Revenue Gneration by European Regions in %, 2016-2017
Figure 13.24: Sysmex Corporation Revenue Generation by Regions in %, 2016-2017
Figure 13.25: EKF Revenue Growth in USD Billion, 2013-2017
Figure 13.26: EKF Revenue Growth in Major Markets in USD Million in %, 2012-2016
Figure 13.27: Werfen Total Sales in Euro Billion and Growth Rate in %, 2014-2016
Figure 13.28: Werfen Regional Sales in %, 2016
Figure 13.29: Danaher Corporation Revenue Growth in USD Billion and Growth Rate in %, 2014-2017
Figure 13.30: Danaher Corporation Revenge Generated through Various Business Segments in %, 2014-2017
Figure 14.1: Europe POCT Devices Future Market Size on the Basis of Revenue in Euro Million, 2018E-2022E
Figure 14.2: Europe POCT Devices Future Market Segmentation on the Basis of Revenue in %, 2022E
Figure 15.1: Europe POCT Devices Analyst Recommendations Overview
Figure 15.2: Europe POCT Devices Analyst Recommendations on Marketing Initiatives.
Figure 15.3: Europe POCT Devices Other Analyst Recommendations


List Of Table

Table 1.1. Europe POCT Devices Market Definition
Table 1.2. Correlation Matrix for Europe POCT Devices Market
Table 1.3. Regression Coefficient Output for Europe POCT Devices Market
Table 2.1: Europe POCT Devices Market Key Growth Drivers and Market Restraints, 2012-2017
Table 5.1: Value Chain Description for Product Manufacturers Including Role Description and Problems Faced in the Value Chain, 2017
Table 5.2: POCT Devices Group Purchasing Organisations, Super Stockist (C&F) & Regional Distributors Including Sub Entities Involved, Role Description and Problems Faced in the Value Chain, 2017
Table 5.3: Europe POCT Devices Retailers Including Sub Entities Involved, Role Description & Problems Faced, 2017
Table 5.4: Europe POCT Device Customers Including Sub Entities Involved, Role Description and Problems Faced in the Value Chain, FY’18
Table 8.1: POCT Devices Market Segmentation by Product Type on the Basis of Revenue Generated in Percentage for Eastern, Western and Entire Europe, 2017
Table 8.2: New Product Launches by Product Category Including Product Name, Company, Price, Launched In and Product Specialties/Functions, 2013-2017
Table 8.3: Blood Glucose POCT Devices Market Segment Including Product Overview, Test Purpose, Instrument & Consumable, Market Size, Major Products and Companies and Others, 2017
Table 8.4: HbA1c POCT Devices Market Segment Including Product Overview, Price Structure, Instrument & Consumable, Market Size, Major Markets, Products and Companies, Market Future and Others, 2017
Table 8.5: Cholesterol POCT Devices Market Segment Including Product Overview, Growth Factors, Instrument & Consumable, Market Size, Products and Companies, Market Future and Others, 2017
Table 8.6: Blood Gas and Electrolytes POCT Devices Market Segment Including Product Overview, Growth Factors, Instrument & Consumable, Leading Countries, Technologies Used and Replacement Time, 2017
Table 8.7: Blood Gas and Electrolytes POCT Devices Market Segment Including Market Size, Major Products, Major Players, Major Developments and Market Future, 2017
Table 8.8: Infectious POCT Devices Market Segment Including Product Overview, Growth Opportunity, Instrument & Consumable, Leading Countries, Major Players, Major Products, Growth Strategies, Technologies and Market Future, 2017
Table 8.9: Infectious POCT Devices Market Segment Including Segment Related Information on Leading Countries Including France, Russia and Germany, 2017
Table 8.10: Pregnancy POCT Devices Market Segment Including Segment Overview, Product Details, Major Players, Market Size & Related Numbers, Germany Top Companies, Product related difficulties faced by the consumers, Best brands and Others, 2017
Table 8.11: Rapid Coagulation POCT Devices Market Segment Including Segment Overview, Key Strengths, Major Players, End Users, Market Size & Related Numbers and Market Future, 2017
Table 8.12: Drug of Abuse POCT Devices Market Segment Including Segment Overview, Consumable, Social Implication, Major Players, Market Size, Product and Prices, 2017
Table 8.13: Cardiac POCT Devices Market Segment Including Segment Overview, Instrument & Consumable, Current Market Trends, Major Players, Market Size, End Users, Major Customers, Future Market Size, 2017
Table 8.14: Hematology POCT Devices Market Segment Including Segment Overview, End Users, Market Size, Major Countries, Major Products, Major Players, Major Issues, Future Market Size, 2017
Table 8.15: Urinalysis POCT Devices Market Segment Including Segment Overview, End Users, Market Size & others, 2017
Table 8.16: Faecal Occult POCT Devices Market Segment Including Segment Overview, End Users, Market Size & others, 2017
Table 9.1: Germany Market Segmentation by Products on the Basis of Revenue Generated in Euro Million, 2012 & 2017
Table 10.1: POCT Devices Market Segmentation by Customer Category Including Key Users, Revenue Generated & Others, 2017
Table 11.1: Europe POCT Market Segmentation by Instruments and Consumables on the Basis of Revenue Generated, 2017
Table 11.2: Cross Comparison of Various Instruments and Consumables Sold by Various Countries in Europe including Best Seller, Diagnosed Product Categories and Others, 2017
Table 12.1: Government Regulations Prevailing in Europe POCT Devices Market Including Definitions and Essential Requirements
Table 12.2: Government Regulations for POCT Devices Market Including Information Required on the label of the Device
Table 12.3: Government Regulations for POCT Devices Market Including Directions of Use, Sterile Packaging and Others
Table 12.3: Government Regulations for POCT Devices Market Including Directions of Use, Sterile Packaging and Others
Table 12.4: Government Regulations for POCT Devices Market Including Technical Documentation, Product Verification and Validation and Changes and Modifications.
Table 12.5: Government Regulations for POCT Devices Market in Germany and the UK Including Technical Documentation, Product Verification and Validation and Changes and Modifications and others.
Table 13.1: Strength & Weaknesses of Top Six Players in Europe POCT Devices Market on the Basis of Products Offered, 2017
Table 13.2: Alere Company Profile Including Overview, Operating Segments, Types of Treatments and Mergers & Acquisitions, 2017
Table 13.3: Alere Company Profile Including Distribution Channel, Customers, R&D, Mergers and Acquisitions and Others, 2017
Table 13.4: Alere Product/Service Portfolio for Cardio Metabolic POCT Solutions Including Type of Disease and Products, 2017
Table 13.5: Alere Product/Service Portfolio for Infectious POCT Solutions Including Type of Disease and Products, 2017
Table 13.6: Alere Product/Service Portfolio for Toxiology (For Hospitals, Employers, Medication Monitoring and Roadside Drug Testing and Other POCT Solutions Including Parameter and Products, 2017
Table 13.7: Roche Holding AG Company Profile Including General Overview, USP, Products and Solutions, 2017
Table 13.8: Roche Holding AG Company Profile Including Business Strategies, Successful Launches, EMEA Revenue, 2017
Table 13.9: Siemens Healthineers Company Profile Including Company Overview and Recent Merger &Acquisition, 2017
Table 13.10: Siemens Healthineers Company Profile Including Company Overview and Recent Merger &Acquisition, 2017
Table 13.11: Siemens Healthineers Company Product Portfolio , 2017
Table 13.12: Becton Dickinson Company Profile Including, Overview, Value Chain, R&D and Others 2017
Table 13.13: Becton Dickinson Company Profile Including Business Strategies, Business Segments and Revenue, 2017
Table 13.14: Sysmex Corporation Company Profile Including Overview, Business Segments, POC Division and Others, 2017
Table 13.15: EKF Diagnostics Holding Company Profile Including Overview, POC Division, Business Strategies, Distribution and Acquisitions, 2017
Table 13.16: EKF Diagnostics Holding Company Profile Including Overview, POC Division, Business Strategies, Distribution and Acquisitions, 2017
Table 13.17: EKF Diagnostics Holding Company Revenue Generated in Various Countries Comprising EMEA Region in Euro Million, 2012-2016
Table 13.18: Business Stream 1- Hematology Product Portfolio and Business Strategies. 2017
Table 13.19: Business Stream 2- Diabetes Care Product Portfolio and Business Strategies. 2017
Table 13.20: Business Stream 2- Diabetes Care Product Portfolio and Business Strategies. 2017
Table 13.21: Business Stream 4-Central Laboratory POCT Product Portfolio, 2017
Table 13.22: PTS Diagnostics Holding Company Profile Including Overview and POCT Product Portfolio, 2017
Table 13.23: PTS Diagnostics Holding Distributors in Europe, 2017
Table 13.24: Werfen Company Profile Including Company Overview, Products Offered, POCT Product Portfolio, Business Strategies, R&D, Mergers & Acquisitions and Others, 2017
Table 13.25: Werfen Company Product Portfolio, 2017
Table 13.26: Danaher Corporation Company Profile Including Company Overview, Diagnostics POCT Segment and Business Strategies, 2017
Table 13.27: Danaher Corporation Company Product Portfolio for POCT Devices and Services, 2017
Table 13.28: Danaher Corporation Company Timeline of Major Acquisitions and Mergers, 2012-Current
Table 13.29: A. Menarini Diagnostics Company Profile Including Overview, POC Division and Business Strategy, 2017
Table 13.30: Various Other Players Operating in Europe POCT Market -Company Profile, 2017
Table 13.31 Various Other Players Operating in Europe POCT Market -Company Profile, 2017
Table 14.1: Western & Eastern Europe Future Market Size on the basis of Revenue in Euro Million, 2018E-2022E
Table 14.2: Europe POCT Devices Future Market Segmentation on the Basis of Revenue in Euro Million and CAGR in %, 2022E

Licence Rights

License Type Excel Only Single User Single User + Excel Hard Copy Corporate User License
User Sharing Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Access to Printed Report; No Soft Copy Multiple Users within the Company/ Enterprise
Print Option
Copy Option :Yes :No
Citation Yes (Not Publically; but to Private Parties within the company/ affiliate)
Deliverable Format :via Email :via Email ; :via Email Printed Publication/ Book by Post ; :via Email
Customization 20%
Analyst Time (Post Purchase Queries on Call/ Email)
Disclaimer : In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Blood Glucose POCT, Infectious POCT, Cardiac POCT, Rapid Coagulation POCT, Blood Gas & Electrolytes POCT, Hematology POCT, Pregnancy POCT, Urinalysis POCT, Cholesterol POCT, Fecal Occult POCT, Hb1Ac POCT & Drugs of Abuse POCT), by Customer Segments (Hospitals & Clinics, Diagnostics Labs & Primary Care Units and Homecare & Patients) and by Instruments and Consumables


Companies

Alere, Roche Holding AG, Siemens Healthineers, Becton Dickinson, Sysmex Corporation, EKF Diagnostics Holding, PTS Diagnostics, Werfen, Danaher Corporation, A. Menarini Diagnostics, Trinity Biotech, FujiFilm

The report titled "Europe POCT Devices Market Outlook to 2022 - by Geography (Western Europe & Eastern Europe), by Product (Blood Glucose POCT, Infectious POCT, Cardiac POCT, Rapid Coagulation POCT, Blood Gas & Electrolytes POCT, Hematology POCT, Pregnancy POCT, Urinalysis POCT, Cholesterol POCT, Fecal Occult POCT, Hb1Ac POCT & Drugs of Abuse POCT), by Customer Segments (Hospitals & Clinics, Diagnostics Labs & Primary Care Units and Homecare & Patients)" provides a comprehensive analysis of Europe POCT devices market evolution and overview, market ecosystem, market nature, value chain & entity analysis (OEM’s, C&F agents, distributors, retailers & customers), market size, and market segments by Geography (Western Europe & Eastern Europe), by Product (Blood Glucose POCT, Infectious POCT, Cardiac POCT, Rapid Coagulation POCT, Blood Gas & Electrolytes POCT, Hematology POCT, Pregnancy POCT, Urinalysis POCT, Cholesterol POCT, Fecal Occult POCT, Hb1Ac POCT & Drugs of Abuse POCT), by Customer Segments (Hospitals & Clinics, Diagnostics Labs & Primary Care Units and Homecare & Patients) and by Instruments and Consumables. Competition landscape, competition nature, major competition parameters and market share of major companies along with company profiles of Alere, Roche Holding AG, Siemens Healthineers, Becton Dickinson, Sysmex Corporation, EKF Diagnostics Holding, PTS Diagnostics, Werfen, Danaher Corporation, A. Menarini Diagnostics, Trinity Biotech, FujiFilm and others have been profoundly covered in the report. The report underscores prevailing government rules and regulation along with analyst recommendation to highlight the major opportunities and cautions.

The report is useful for POCT Devices manufacturers, distributors, retailers, potential entrants and other stakeholders to align their market centric strategies according to ongoing and expected trends in the future.

Europe POCT Devices Market Size and Overview

Market Size: Europe POCT Devices Market has grown registering a robust CAGR of close to 8% during the review period. Currently, the market is in growth stage with high potential of future expansion in both developed and developing countries of the region. Various factors supporting growth include high incidence of chronic diseases, rising health awareness, medical advancement in POCT sector, advancement in medical knowledge and R&D work, unease associated with laboratory testing methods and new companies venturing the market. Increase in urban population especially in the metro-cities which has been the largest end-user segment of the market and higher spending on R&D activities by the companies has led to the rise in number of point of care testing devices & customer interest. A substantial increase in awareness amongst population in cities & smaller towns has provided major thrust to this market. In parallel, growth & popularity of pregnancy & blood glucose POCT and advancement in technologies have given rise to new and improved devices. Advent of deadly infectious and cardiac diseases has led people to use these devices for quick detection. However, the market has been flooded with “fake” products, found all throughout the value chain.

Market Segmentation

By Geography: Western Europe has led the overall European scenario in terms of sales of POCT devices in 2017. Advanced medical infrastructure, higher level of disposable income of people, higher awareness and spending on healthcare, presence of well established manufacturers and government support has enabled countries such as the UK, France and Germany to lead the overall European landscape in terms of both, sales and demand in the review period.

By Product: Blood Glucose POCT devices led the market with highest sales revenue in 2017. The devices are used on routine basis to monitor glucose levels for people at home or for patients under tight glycemic control requirements. This segment was followed by Infectious, Cardiac, Rapid Coagulation, Blood Gas and Electrolytes, Hematology, Pregnancy POCT, Urinalysis POCT, Cholesterol Fecal Occult, Drugs of Abuse and Hb1Ac POCT devices respectively.

By Customer Segment: Hospitals and Clinics have been the largest customers of POCT devices in Europe in 2017. The entity uses these devices for diagnostics, treatment, monitoring and rapid testing. The tests carried out consists of TB, HIV, Malaria, Syphilis, Dengue, Strep A, HBV, C Diff, CD, 4, HCV, MRSA, Flu, UTI, Viral and others. Diagnostic labs and primary care units constitute for second largest share in the market. Home care and patients occupied lowest share owing to low volume sales and low replacement demand. Major motive to buy a POCT device for home patients is self assessment & referral and cost reduction.

By Instruments and Consumables: Instruments comprise of an apparatus or a machine that is used in the diagnosis of an illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for some health purpose. Consumables primarily comprise of strip based instruments such as Electrochemical or reflectance strip-based glucose meters and INR analyzers. HbA1c, Pregnancy, Cholesterol and Drug of Abuse POCT devices utilize consumables in large scale for diagnostics.

Competitive Landscape
Competition in the market has been concentrated among 6 major & 10-15 smaller companies in 2017. These include Radiometer, Werfen, Siemens, Roche, Nova, Alere and others. Major competition is being driven through new product launches, innovation and marketing initiatives. Products are being manufactured domestically as well as imported.

Future Outlook and Tailwind
Market has been anticipated to showcase a substantial growth at a CAGR of close to 6% during the forecast period. Increase in the number of new entrants in the market, larger product acceptance, new product launches, expanding distribution channels of existing players and higher marketing expenditure done by the companies are expected to be tailwind for future growth.

Key Topics Covered in the Report

  • Europe POCT Devices Market Introduction & Timeline
  • Europe POCT Devices Market Size, 2012-2017
  • Market Segmentation by Geography (Western Europe & Eastern Europe), by Product (Blood Glucose POCT, Infectious POCT, Cardiac POCT, Rapid Coagulation POCT, Blood Gas & Electrolytes POCT, Hematology POCT, Pregnancy POCT, Urinalysis POCT, Cholesterol POCT, Fecal Occult POCT, Hb1Ac POCT & Drugs of Abuse POCT), by Customer Segments (Hospitals & Clinics, Diagnostics Labs & Primary Care Units and Homecare & Patients) and by Instruments and Consumables.
  • Company Profiles of Major Manufacturers (Alere, Roche Holding AG, Siemens Healthineers, Becton Dickinson, Sysmex Corporation, EKF Diagnostics Holding, PTS Diagnostics, Werfen, Danaher Corporation, A. Menarini Diagnostics, Trinity Biotech, FujiFilm and others)
  • Value Chain Analysis Europe POCT Devices Market
  • Government Rules and Regulations for Europe POCT Devices Market
  • Growth Drivers in Europe POCT Devices Market
  • Major Market restraints in Europe POCT Devices Market
  • Future Outlook to Europe POCT Devices Market
  • Analyst Recommendation
READ MORE

Scope

1. Research Methodology-Market Definitions

1.1 Abbreviations
1.2. Consolidated Research Approach
1.3. Research Methodology-Market Sizing and Limitations
1.4. Research Methodology - Variables (Dependent and Independent)

Variables Considered:

1.5. Research Methodology – Europe POCT Devices Market
1.6. Research Methodology – Europe POCT Devices Market

2. Europe POCT Devices-Executive Summary

3. Europe POCT Market Ecosystem: Vendor Landscape

4. Europe POCT Devices Market: Timeline & Genesis

5. Europe POCT Devices Market Value Chain Analysis -Overview

5.1. Value Chain Analysis for Europe POCT Devices Market-Networking
5.2. Entity Analysis: POCT Device Manufacturers (OEMs)
5.3. Entity Analysis: GPO, IDN, Stockists & Regional Distributors
5.4. Entity Analysis: Retailers (Pharmacy Chains & E-Commerce)
5.5. Entity Analysis: Final Consumers (Retail & Institutional)

6. Europe Point of Care Testing Devices Market, 2012-2017

7. Europe Point of Care Testing Market Key Trends & Growth Drivers

8. Europe Point of Care Testing Devices Market Segmentation by Product Type on the Basis of Revenue, 2017

8.1. Europe POCT Devices Market Segmentation by Product Type-Eastern and Western Europe
8.2. Europe POCT Devices Market New Technology Advancements
8.3. Blood Glucose Point of Care Testing, 2017
8.4. HbA1c Point-of Care Testing, 2017
8.5. Point-Cholesterol Point of Care Testing Devices, 2017
8.6. Blood Gas and Electrolytes Point of Care Testing Devices, 2017
8.7. Infectious Point of Care Testing Devices, 2017
8.8. Pregnancy Point of Care Testing Devices, 2017
8.9. Rapid Coagulation Point of Care Testing Devices, 2017
8.10 Drug of Abuse Point of Care Testing Devices, 2017
8.11. Cardiac POCT Devices, 2017
8.12. Hematology POCT Devices, 2017
8.13. Urinalysis & Faecal Occult POCT Devices, 2017

9. Europe POCT Devices Market Segmentation by Countries, 2017

9.1 Germany
9.2 Italy
9.3. Spain
9.4. UK
9.5. Scandinavian Countries
9.6. France
9.7. Russia
9.8. Poland
9.9 Greece

10. POCT Devices Market Segmentation by B2B & B2C Customer Type, 2017

11. POCT Market Segmentation by Instruments & Consumables, 2017

12. Government Regulations: Product Definitions and Essential Requirements

12.1. Government Regulations Involving Information Supplied by Manufacturer
12.2. Government Regulations: Product Definitions and Essential Requirements
12.3. Government Regulations: Product Definitions and Essential Requirements (Germany and United Kingdom)

13. Company Profile

13.1. Alere Inc.
13.2. Roche Holding AG
13.3. Siemens Healthineers
13.4. Becton Dickinson
13.5. Sysmex Corporation
13.6. Entwicklung, Konstruktion und Fertigung (EKF) Diagnostics Holding
13.7. PTS Diagnostics
13.8. Werfen
13.9. Danaher Corporation
13.10. A. Menarini Diagnostics
13.11. Other Companies

14. Europe Point of Care Test Devices Future Market Outlook and Projections, 2018E-2022E

14.1. Market Segmentation by Product Category, 2022E

15. Analyst Recommendations


List Of Figure

Figure 1.1 Tentative Respondents breakdown by Entities 
Figure 2.1: Europe POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 2.2 Europe POCT Devices Market Segmentation by Product on the basis of Revenue in %, 2017
Figure 2.3: Europe POCT Devices Key Market Matrix
Figure 3.1. Europe POCT Devices Market Ecosystem Including Vendor Landscape and Device Retailors
Figure 4.1. Europe POCT Market Timeline Including Establishment or Commencement of POCT Related Operations in Europe and Market Push Factors.
Figure 5.1: Europe POCT Market Product Development and Supply Chain Consisting of Major Entities and Sales Shares.
Figure 5.2: Modes of Product Pitching, Dealer Networks, Marketing Channels, Incentive Programs, Margins Charged by Major Entities in Europe POCT Devices Market.
Figure 6.1: Europe POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2017
Figure 6.2: Western Europe POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2017
Figure 6.3: Eastern Europe POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2017
Figure 8.1: Europe POCT Devices Market Segmentation by Product Type on the Basis of Revenue Generated in Percentage, 2017
Figure 8.2: Europe POCT Devices Market Segmentation by Product Type in Percentage for Eastern and Western Europe, 2017
Figure 8.3: Blood Glucose POCT Devices Market Segment Including Product Genesis, Strengths & Weakness, 2017
Figure 8.4: Blood Glucose POCT Devices Market Segment country wise analysis including major players, recent development and others, 2017
Figure 8.5: Infectious POCT Devices Market Including European Union Horizon 2020 Program, RSV Infection Project, Different Types of Infectious Diseases and others, 2017
Figure 9.1: Market Share of Major Countries in Europe POCT Devices Market by Revenue Generation, 2017
Figure 9.2: Market Share of Major Countries in Eastern Europe POCT Devices Market by Revenue Generation, 2017
Figure 9.4: Germany Market Segmentation by Product Categories on the Basis of Revenue Generated in %, 2012 and 2017
Figure 9.5: Germany Market Segmentation by Customer Segment on the Basis of Revenue Generated in %, 2017
Figure 9.7: Italy POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 9.8: Italy POCT Market Segmentation by Product Categories on the Basis of Revenue Generated in %, 2017
Figure 9.9: Italy POCT Market Segmentation by Instruments & Consumables on the Basis of Revenue Generated in %, 2017
Figure 9.10: Italy POCT Market Segmentation by Clientele on the Basis of Revenue Generated in %, 2017
Figure 9.11: Market Share of Major Players in Italy POCT Market on the Basis of Revenue Generated in %, 2017
Figure 9.12: Spain POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 9.13: UK POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 9.14: Scandinavian Countries POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 9.15: Market Share of Various (Sweden, Norway and Denmark) Scandinavian Countries POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 9.16: France POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 9.17: France Market Segmentation by Product Categories on the Basis of Revenue Generated in %, 2017
Figure 9.18: France Market Segmentation by Instruments & Consumables on the Basis of Revenue Generated in %, 2017
Figure 9.19: France Market Segmentation by End Users on the Basis of Revenue Generated in %, 2017
Figure 9.20: Greece POCT Devices Market Size on the Basis of Revenue in Euro Million, 2012-2022E
Figure 9.21: Greece Market Segmentation by End Users on the Basis of Revenue Generated in %, 2017
Figure 9.22: Greece Market Segmentation by Instruments & Consumables on the Basis of Revenue Generated in %, 2017
Figure 9.23: Italy Market Share of Major Players in Blood Gas and Electrolytes on the Basis of Revenue Generated in %, 2017
Figure 9.24: Italy Market Share of Major Players on the Basis of Revenue Generated in %, 2017
Figure 10.1: *Europe POCT Devices Market Segmentation by Customer Type (B2B & B2C) by Revenue, 2017
Figure 11.1: Europe POCT Market Segmentation by Instruments and Consumables on the basis of Revenue Generated, 2017
Figure 13.1: Competition Parameters amongst Leading Players in the Market, 2017
Figure 13.2: Market Share of Major Players in Europe on the Basis of Revenue Generated in %, 2017
Figure 13.3: Market Share of Major Players in Western Europe POCT Devices Market by Revenue Generation, 2017
Figure 13.4: Alere Revenue Growth in USD Billion, 2012-2016
Figure 13.5: Alere Loss Before Tax in USD Million, 2012-2016
Figure 13.6: Alere Revenue by Region in Percentage, 2016
Figure 13.7: Alere Segment Revenue in Percentage, 2016
Figure 13.8 : Alere Professional Diagnostics Segmentation by Sub Categories on the basis of Revenue in %, 2012-2016
Figure 13.9: Roche Holding AG European Presence Including Sales Sites, Manufacturing Sites, R&D Sites and Headquarters, 2017
Figure 13.10: Roche Diagnostics Revenue Growth in Euro Billion, 2012-2017
Figure 13.11: Roche Holding AG Products offered, Diseases Diagnosed, Solutions and Personalized Treatment Theory.
Figure 13.12: Siemens Healthineers Revenue Growth in Euro Billion, 2013-2017
Figure 13.13: Siemens Healthineers Profit Earned in Euro Billion, 2013-2017
Figure 13.14: Simens Healthineers Number of Orders Billion, 2013-2017
Figure 13.15: Simens Healthineers Profit Margin in Percentage, 2013-2017
Figure 13.16: Siemens Healthineers Revenue Segmentation by Location of Customers in %, 2013-2017
Figure 13.17: Siemens Healthineers Revenue Segmentation by Location of Companies in %, 2013-2017
Figure 13.18: Becton Dickinson Revenue Growth in USD Million, 2013-2017
Figure 13.19: Becton Dickinson Segment Revenue in %, 2013-2017
Figure 13.20 Sysmex Corporation Revenue Growth in USD Billion, 2013-2017
Figure 13.21: Sysmex Corporation Operating Profit in USD Million, 2013-2017
Figure 13.22: Sysmex Corporation Product Segment Revenue in %, 2016-2017
Figure 13.23: Sysmex Corporation Revenue Gneration by European Regions in %, 2016-2017
Figure 13.24: Sysmex Corporation Revenue Generation by Regions in %, 2016-2017
Figure 13.25: EKF Revenue Growth in USD Billion, 2013-2017
Figure 13.26: EKF Revenue Growth in Major Markets in USD Million in %, 2012-2016
Figure 13.27: Werfen Total Sales in Euro Billion and Growth Rate in %, 2014-2016
Figure 13.28: Werfen Regional Sales in %, 2016
Figure 13.29: Danaher Corporation Revenue Growth in USD Billion and Growth Rate in %, 2014-2017
Figure 13.30: Danaher Corporation Revenge Generated through Various Business Segments in %, 2014-2017
Figure 14.1: Europe POCT Devices Future Market Size on the Basis of Revenue in Euro Million, 2018E-2022E
Figure 14.2: Europe POCT Devices Future Market Segmentation on the Basis of Revenue in %, 2022E
Figure 15.1: Europe POCT Devices Analyst Recommendations Overview
Figure 15.2: Europe POCT Devices Analyst Recommendations on Marketing Initiatives.
Figure 15.3: Europe POCT Devices Other Analyst Recommendations


List Of Table

Table 1.1. Europe POCT Devices Market Definition
Table 1.2. Correlation Matrix for Europe POCT Devices Market
Table 1.3. Regression Coefficient Output for Europe POCT Devices Market
Table 2.1: Europe POCT Devices Market Key Growth Drivers and Market Restraints, 2012-2017
Table 5.1: Value Chain Description for Product Manufacturers Including Role Description and Problems Faced in the Value Chain, 2017
Table 5.2: POCT Devices Group Purchasing Organisations, Super Stockist (C&F) & Regional Distributors Including Sub Entities Involved, Role Description and Problems Faced in the Value Chain, 2017
Table 5.3: Europe POCT Devices Retailers Including Sub Entities Involved, Role Description & Problems Faced, 2017
Table 5.4: Europe POCT Device Customers Including Sub Entities Involved, Role Description and Problems Faced in the Value Chain, FY’18
Table 8.1: POCT Devices Market Segmentation by Product Type on the Basis of Revenue Generated in Percentage for Eastern, Western and Entire Europe, 2017
Table 8.2: New Product Launches by Product Category Including Product Name, Company, Price, Launched In and Product Specialties/Functions, 2013-2017
Table 8.3: Blood Glucose POCT Devices Market Segment Including Product Overview, Test Purpose, Instrument & Consumable, Market Size, Major Products and Companies and Others, 2017
Table 8.4: HbA1c POCT Devices Market Segment Including Product Overview, Price Structure, Instrument & Consumable, Market Size, Major Markets, Products and Companies, Market Future and Others, 2017
Table 8.5: Cholesterol POCT Devices Market Segment Including Product Overview, Growth Factors, Instrument & Consumable, Market Size, Products and Companies, Market Future and Others, 2017
Table 8.6: Blood Gas and Electrolytes POCT Devices Market Segment Including Product Overview, Growth Factors, Instrument & Consumable, Leading Countries, Technologies Used and Replacement Time, 2017
Table 8.7: Blood Gas and Electrolytes POCT Devices Market Segment Including Market Size, Major Products, Major Players, Major Developments and Market Future, 2017
Table 8.8: Infectious POCT Devices Market Segment Including Product Overview, Growth Opportunity, Instrument & Consumable, Leading Countries, Major Players, Major Products, Growth Strategies, Technologies and Market Future, 2017
Table 8.9: Infectious POCT Devices Market Segment Including Segment Related Information on Leading Countries Including France, Russia and Germany, 2017
Table 8.10: Pregnancy POCT Devices Market Segment Including Segment Overview, Product Details, Major Players, Market Size & Related Numbers, Germany Top Companies, Product related difficulties faced by the consumers, Best brands and Others, 2017
Table 8.11: Rapid Coagulation POCT Devices Market Segment Including Segment Overview, Key Strengths, Major Players, End Users, Market Size & Related Numbers and Market Future, 2017
Table 8.12: Drug of Abuse POCT Devices Market Segment Including Segment Overview, Consumable, Social Implication, Major Players, Market Size, Product and Prices, 2017
Table 8.13: Cardiac POCT Devices Market Segment Including Segment Overview, Instrument & Consumable, Current Market Trends, Major Players, Market Size, End Users, Major Customers, Future Market Size, 2017
Table 8.14: Hematology POCT Devices Market Segment Including Segment Overview, End Users, Market Size, Major Countries, Major Products, Major Players, Major Issues, Future Market Size, 2017
Table 8.15: Urinalysis POCT Devices Market Segment Including Segment Overview, End Users, Market Size & others, 2017
Table 8.16: Faecal Occult POCT Devices Market Segment Including Segment Overview, End Users, Market Size & others, 2017
Table 9.1: Germany Market Segmentation by Products on the Basis of Revenue Generated in Euro Million, 2012 & 2017
Table 10.1: POCT Devices Market Segmentation by Customer Category Including Key Users, Revenue Generated & Others, 2017
Table 11.1: Europe POCT Market Segmentation by Instruments and Consumables on the Basis of Revenue Generated, 2017
Table 11.2: Cross Comparison of Various Instruments and Consumables Sold by Various Countries in Europe including Best Seller, Diagnosed Product Categories and Others, 2017
Table 12.1: Government Regulations Prevailing in Europe POCT Devices Market Including Definitions and Essential Requirements
Table 12.2: Government Regulations for POCT Devices Market Including Information Required on the label of the Device
Table 12.3: Government Regulations for POCT Devices Market Including Directions of Use, Sterile Packaging and Others
Table 12.3: Government Regulations for POCT Devices Market Including Directions of Use, Sterile Packaging and Others
Table 12.4: Government Regulations for POCT Devices Market Including Technical Documentation, Product Verification and Validation and Changes and Modifications.
Table 12.5: Government Regulations for POCT Devices Market in Germany and the UK Including Technical Documentation, Product Verification and Validation and Changes and Modifications and others.
Table 13.1: Strength & Weaknesses of Top Six Players in Europe POCT Devices Market on the Basis of Products Offered, 2017
Table 13.2: Alere Company Profile Including Overview, Operating Segments, Types of Treatments and Mergers & Acquisitions, 2017
Table 13.3: Alere Company Profile Including Distribution Channel, Customers, R&D, Mergers and Acquisitions and Others, 2017
Table 13.4: Alere Product/Service Portfolio for Cardio Metabolic POCT Solutions Including Type of Disease and Products, 2017
Table 13.5: Alere Product/Service Portfolio for Infectious POCT Solutions Including Type of Disease and Products, 2017
Table 13.6: Alere Product/Service Portfolio for Toxiology (For Hospitals, Employers, Medication Monitoring and Roadside Drug Testing and Other POCT Solutions Including Parameter and Products, 2017
Table 13.7: Roche Holding AG Company Profile Including General Overview, USP, Products and Solutions, 2017
Table 13.8: Roche Holding AG Company Profile Including Business Strategies, Successful Launches, EMEA Revenue, 2017
Table 13.9: Siemens Healthineers Company Profile Including Company Overview and Recent Merger &Acquisition, 2017
Table 13.10: Siemens Healthineers Company Profile Including Company Overview and Recent Merger &Acquisition, 2017
Table 13.11: Siemens Healthineers Company Product Portfolio , 2017
Table 13.12: Becton Dickinson Company Profile Including, Overview, Value Chain, R&D and Others 2017
Table 13.13: Becton Dickinson Company Profile Including Business Strategies, Business Segments and Revenue, 2017
Table 13.14: Sysmex Corporation Company Profile Including Overview, Business Segments, POC Division and Others, 2017
Table 13.15: EKF Diagnostics Holding Company Profile Including Overview, POC Division, Business Strategies, Distribution and Acquisitions, 2017
Table 13.16: EKF Diagnostics Holding Company Profile Including Overview, POC Division, Business Strategies, Distribution and Acquisitions, 2017
Table 13.17: EKF Diagnostics Holding Company Revenue Generated in Various Countries Comprising EMEA Region in Euro Million, 2012-2016
Table 13.18: Business Stream 1- Hematology Product Portfolio and Business Strategies. 2017
Table 13.19: Business Stream 2- Diabetes Care Product Portfolio and Business Strategies. 2017
Table 13.20: Business Stream 2- Diabetes Care Product Portfolio and Business Strategies. 2017
Table 13.21: Business Stream 4-Central Laboratory POCT Product Portfolio, 2017
Table 13.22: PTS Diagnostics Holding Company Profile Including Overview and POCT Product Portfolio, 2017
Table 13.23: PTS Diagnostics Holding Distributors in Europe, 2017
Table 13.24: Werfen Company Profile Including Company Overview, Products Offered, POCT Product Portfolio, Business Strategies, R&D, Mergers & Acquisitions and Others, 2017
Table 13.25: Werfen Company Product Portfolio, 2017
Table 13.26: Danaher Corporation Company Profile Including Company Overview, Diagnostics POCT Segment and Business Strategies, 2017
Table 13.27: Danaher Corporation Company Product Portfolio for POCT Devices and Services, 2017
Table 13.28: Danaher Corporation Company Timeline of Major Acquisitions and Mergers, 2012-Current
Table 13.29: A. Menarini Diagnostics Company Profile Including Overview, POC Division and Business Strategy, 2017
Table 13.30: Various Other Players Operating in Europe POCT Market -Company Profile, 2017
Table 13.31 Various Other Players Operating in Europe POCT Market -Company Profile, 2017
Table 14.1: Western & Eastern Europe Future Market Size on the basis of Revenue in Euro Million, 2018E-2022E
Table 14.2: Europe POCT Devices Future Market Segmentation on the Basis of Revenue in Euro Million and CAGR in %, 2022E

License Type Excel Only Single User Single User + Excel Hard Copy Corporate User License
User Sharing Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Access to Printed Report; No Soft Copy Multiple Users within the Company/ Enterprise
Print Option
Copy Option :Yes :No
Citation Yes (Not Publically; but to Private Parties within the company/ affiliate)
Deliverable Format :via Email :via Email ; :via Email Printed Publication/ Book by Post ; :via Email
Customization 20%
Analyst Time (Post Purchase Queries on Call/ Email)
Disclaimer : In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.
To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Blood Glucose POCT, Infectious POCT, Cardiac POCT, Rapid Coagulation POCT, Blood Gas & Electrolytes POCT, Hematology POCT, Pregnancy POCT, Urinalysis POCT, Cholesterol POCT, Fecal Occult POCT, Hb1Ac POCT & Drugs of Abuse POCT), by Customer Segments (Hospitals & Clinics, Diagnostics Labs & Primary Care Units and Homecare & Patients) and by Instruments and Consumables


Companies

Alere, Roche Holding AG, Siemens Healthineers, Becton Dickinson, Sysmex Corporation, EKF Diagnostics Holding, PTS Diagnostics, Werfen, Danaher Corporation, A. Menarini Diagnostics, Trinity Biotech, FujiFilm